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Abstract
H-Ras oncogene requires deregulation of additional oncogenes or inactivation of tumor suppressor proteins to increase cell
proliferation rate and transform cells. In fact, the expression of the constitutively activated H-RasV12 induces cell growth
arrest and premature senescence, which act like barriers in pre-neoplastic lesions. In our experimental model, human
fibroblasts transfected with H-RasV12 show a dramatic modification of morphology. H-RasV12 expressing cells also show
premature senescence followed by cell death, induced by autophagy and apoptosis. In this context, we provide evidence
that in H-RasV12 expressing cells, the premature senescence is associated with cellular redox imbalance as well as with
altered post-translation protein modification. In particular, redox imbalance is due to a strong reduction of total antioxidant
capacity, and significant decrease of glutathione level. As the reversible addition of glutathione to cysteinyl residues of
proteins is an important post-translational regulative modification, we investigated S-glutathionylation in cells expressing
active H-Ras. In this contest we observed different S-glutathionylation patterns in control and H-RasV12 expressing cells.
Particularly, the GAPDH enzyme showed S-glutathionylation increase and significant enzyme activity depletion in H-Ras V12
cells. In conclusion, we proposed that antioxidant defense reduction, glutathione depletion and subsequent modification of
S-glutathionylation of target proteins contribute to arrest cell growth, leading to death of fibroblasts expressing
constitutively active H-Ras oncogene, thus acting as oncogenic barriers that obstacle the progression of cell transformation.
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Introduction
Oncogene deregulation is not sufficient to induce cellular
proliferation and tumorigenic transformation, which are caused by
a variety of cooperating mechanisms. Deregulated oncogenes can
increase cellular proliferation rate, but they require additional
oncogenes or inactivation of tumour suppressor genes such as p53
or pRb to fully transform cells [1–3]. In absence of cooperating
mutations, deregulated oncogene activation typically leads to cell
cycle arrest, premature senescence and cell death by apoptotosis
and autophagy [4–7]. These responses act as a tumor suppressor
mechanism in the pre-malignant stage of tumorigenesis in order to
prevent the progression of oncogenic transformation [8]. Consti-
tutively activated H-RasV12 oncogene induces proliferative arrest
and premature senescence in normal fibroblasts (OIS, Oncogene
Induced Senescence). These events have been associated with
DNA damage and activation of DNA damage response (DDR),
which is considered an efficient oncogenic barrier [9–10]. Data
supporting the activation of DDR by DNA replication stress do
not preclude that other types of cell damaging stresses may
contribute to OIS and be considered as additional oncogenic
barriers [11–13]. Furthermore when cells are stimulated to
proliferate as in the case of H-RasV12 oncogene expression, the
stress due to hyper-proliferation certainly affects many cell
structures and not only nuclear DNA.
ROS-mediated cell damage has long been thought to play a role
in carcinogenesis initiation and malignant transformation [14,15].
In fact, many malignant cell types possess an abnormal redox
metabolism, which consists in deregulation of antioxidant en-
zymes, impaired mitochondrial function and enhancement of
reactive oxygen species (ROS) production [16]. On the other
hand, ROS are considered as second messengers because they
may regulate the strength and duration of signalling through
redox-dependent signal transduction pathways, via the cyclic
oxidation/reduction of cysteine residue in kinase, phosphatases
and other regulatory factors [15,17]. Reactive thiols in proteins are
subject to a wide array of irreversible modifications in oxidation
state, including oxidation to sulfenic (-SOH), sulfinic (-SO2H), and
sulfonic (-SO3) acid and formation of disulfide bridges. Since these
over-oxidation reactions are by nature irreversible, the thiol
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modifications usually play only a minor role in controlling redox–
regulated proteins [18], whereas changes in the reversible
oxidation state of cysteine residues, such as nitrosylation and
glutathionylation, are important post-translational protein mod-
ifications with a critical role in signal transduction. Protein S-
glutathionylation (protein-SSG) plays a dual role in cell biology –
as an antioxidant because it provides protection of protein
cysteines from irreversible oxidation and as signal transduction
mechanism [19,20]. S-glutathionylation is an important mecha-
nism for dynamic post-translational regulation of a variety of
regulatory, structural and metabolic proteins [21,22]. In particu-
lar, signalling proteins (especially kinases and phosphatases),
cytoskeleton proteins, proteins involved in metabolism and energy,
folding proteins and redox homeostasis protein appear to be
regulated by S-glutathionylation [23]. S-glutathionylation consists
in the reversible formation of mixed disulfides between glutathione
and protein cysteinyl residues of proteins and has a critical role in
sulfhydryl homeostasis. Since glutathione (GSH) is considered as
a thiol redox buffer, S-glutathionylation can be directly linked to
the redox status of cell GSH [24,25]. Interestingly, it has been
reported that S-glutathionylation may modulate the activity of
oncogenes such as Ras or transcription factors like p53 [26,27] and
also that GSH is involved in regulating the activation of various
key proteins regulating cell proliferation, including nuclear factor
NF-kB and activator protein AP-1. [28–30].
In various types of tumor cells the high content of GSH
generally increases antioxidant capacity and resistance to oxidative
stress, and makes cancer cells chemo-resistant. Although neither
the mechanism nor the implications of these changes are well
defined, agents that deplete GSH, such as buthionine sulfoximine,
have shown clinical anti-cancer activity; thus is it possible to
suppose that the high GSH content may be necessary for cancer
cell survival [31–33]. To gain insight the mechanism of Ras-
initiated cell death and the role of GSH in pre-malignant cells
model, we used human fibroblasts expressing constitutively active
H-RasV12 and evaluated redox balance, GSH:GSSG ratio and
protein S-glutathionylation level and pattern. In this study, we
demonstrate that expressing constitutively active H-Ras oncogene
induced cell cycle progression and that the cells activated the
pathways for induced premature senescence followed by autop-
hagy and apoptosis. During the senescence state we observed cell
redox imbalance that involved antioxidant defense reduction,
glutathione depletion and modification of S-glutathionylation
pattern. Finally, our study brings a better understanding to the
role of redox cell system in OIS.
Materials and Methods
Reagents
All cell culture reagents were obtained by PAA the cell culture
company (Pasching, Austria). All chemical reagents were obtained
by Sigma Aldrich (Sigma, St Louis, MO, USA). Lipofectamine
LTX with expression vector pcDNATM6/myc-His and Blasticidin-
S, Annexin V-FITC Apoptosis Detection kit and carboxy-
H2DCFDA (C400) were supplied by Invitrogen (Invitrogen,
Carlsbad, CA, USA), ‘‘In situ cell proliferation kit FLUOS’’ was
supplied by Roche (Roche Diagnostics GmbH, Mannheim,
Germany), mouse monoclonal anti-glutathione antibody and
rabbit polyclonal anti-H Ras antibody were supplied by Santa
Cruz Biotechnology (Santa Cruz Biotechnology, CA, USA), and
ImmobilineTMDryStrip pH 3–10 non linear supplied by GE
Healthcare. pSG5-RasV12, was kindly provided by Dr. Giuliana
Pelicci, Department of Experimental Oncology, European In-
stitute of Oncology, Milan, Italy.
Cell Culture and Growth Curve
HuDE (human dermal fibroblasts) were purchased from the
Istituto Zooprofilattico Sperimentale, Brescia, Italy. The cells were
cultured in DMEM medium supplemented with 10% (v/v) heat
inactivated fetal calf serum, 2 mM glutamine, 10 U/ml penicillin,
10 mg/ml streptomycin at 37uC in a humidified atmosphere
containing 5% (v/v) CO2. Cell growth was determined by
counting cell numbers in a haemocytometer. The viability of the
cells was estimated by examining their ability to exclude Trypan
blue (0.1% in 0.9% NaCl).
pcDNA6 Vectors and H-Ras Mutant Expression
Cells were transfected by lipofection using Lipofectamine LTX
with the expression vector pcDNATM6/myc-His encoding the
constitutively active mutant H-RasV12. This mutation involves
the replacement of the amino acid glycine with a valine, which
makes the GTPase constitutively GTP bound. The vector
expressing the Ras mutant was obtained by subcloning H-RasV12
from pSG5 vector into the EcoRI site of pcDNATM6/myc-His.
Transiently transfected fibroblasts were selected using 4mg/ml
Blasticidin-S for 5 days.
Cellular Extracts
Cell samples were washed twice with 0.9% NaCl (500 g for 10
minutes in top centrifuge) and suspended in 10 mM sodium
phosphate pH 6.0 buffer. Cellular suspensions were lysed by 5
freeze (in liquid nitrogen) and thaw (room temperature) cycles.
Total cells disruption was validated using trypan blue staining.
Lysates were centrifuged at 16,000 g (20 minutes, 4uC). Extracts
for immunoblotting were obtained by treating cells with 10 mM
sodium phosphate pH 6.0 buffer and 0.5% (v/v) Nonidet P40
detergent. After 1 h incubation on ice, they were centrifuged at
16,000 g for 20 minutes. All procedures were carried out at 4uC.
Supernatants were recovered and the protein content was
determined by the method of Bradford [34] using BSA as
standard.
Cell Cycle Analysis
All cells were analyzed using a Beckman Coulter Epics XL flow
cytometer and all measurements were performed under the same
instrument setting. FACS DNA content analysis was carried out
by propidium iodide method. Cells were harvested and washed
twice with cold PBS and fixed with 70% ice cold ethanol for 2 h at
4uC. The fixed cells were suspended in a master mix solution
containing PBS, propidium iodide (final concentration: 40 mg/ml)
and DNase-free RNaseA (final concentration: 100 mg/ml) for 30
minutes at room temperature in the dark. At least 10,000 cells for
each sample were measured. The percentage of cell cycle phases
(G0/G1, S, and G2/M) was quantified by MultiCycle AV DNA
analysis plug-in for FCS Express (De Novo Software, CA, USA).
Control and H-RasV12 cells were seeded in 6-multiwell after
selection with basticidin-S, in order to detect S-phase cells and
determine cell cycle kinetics. Cells were treated with 40 mM
bromodeoxyuridine (BrdU) for 30 minutes at 37uC and grown in
fresh medium for 3, 6, 18 and 24 h, then fixed O/N in 70%
ethanol. Immunostaining and flow cytometry analyses were
carried out with ‘‘In situ cell proliferation kit FLUOS’’, according
to the manufacturer’s instructions. BrdU untreated cells were used
as negative control at each time point. At least 10,000 cells for
each sample were measured for BrdU positive staining. The
percentage of BrdU positive cells was quantified subtracting the
negative control at any time point.
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Figure 1. Analysis of cell growth and cell cycle. A) Immunoblotting analysis of H-RasV12 transfected cells. Cell extracts were incubated with an
anti-H-Ras antibody. As internal control an anti-b actin antibody was used. The increased expression of H-Ras in transfected cells compared to empty
vector transfected cells (control) is shown. B) Growth curve of HuDe fibroblasts transfected with empty vector and H-RasV12. The cell number
increase after the end of the selection with blasticidin-S (4 mg/ml) is reported. Mean values were calculated on 5 replicates and mean 6 s.d. was
indicated for each sample. C) Cell morphology analysis by light microscopy, 2006 total magnification. D) Flow cytometry cell cycle analysis of
H-Ras Induced Changes of S-glutathionylation
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Apoptosis Analysis
Apoptosis was analyzed by flow cytometry, using Annexin V-
FITC Apoptosis Detection kit, according to the manufacturer’s
instructions. Briefly, control and H-RasV12 cells were trypsinized,
washed twice with cold PBS and resuspended in 1X Binding
Buffer at final concentration of 1,06106 cell/ml. Annexin V-FITC
(0.25 mg/ml) and Propidium Iodide (PI) (1 mg/ml) were added to
cell suspension and incubated for 10 minutes at room temperature,
protected from light. Samples were analyzed using Beckman
Coulter EPICS XL flow cytometer. For each sample 10,000 events
were acquired. Annexin V-FITC is detected as a green fluores-
cence and propidium iodide is detected as a red fluorescence.
Early apoptosis is defined by Annexin V+/PI2 staining, late
apoptosis is defined by Annexin V+/PI+ staining and necrosis is
defined by Annexin V2/PI+ staining.
Senescence-associated b-galactosidase Staining
Senescent cells were evaluated by SA-b-galactosidase (SA-b-gal)
staining as described previously [35]. Control and H-RasV12
transfected cells were seeded in 6-multiwell plates. 24 h after the
seeding, cells were washed once with phosphate buffer saline (PBS)
and then fixed with 0.5% glutaraldehyde in PBS for 15 minutes at
room temperature. Plates were washed twice with PBS. Cells were
incubated at 37uC overnight with the staining solution (5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM
MgCl2 in 100 mM citric acid and 200 mM Na2HPO4 solutions
pH 6.0, 1 mg/ml 5-bromo-4-chloro-3-indolyl b-D-galactopyrano-
side). Blue color development was checked under microscope
using 606 total magnification. Positive fibroblasts were counted
and results were expressed as mean 6 s.e.m. of the percentage of
SA-b-gal positive fibroblasts with respect to the total number of
fibroblasts.
Reactive Oxygen Species (ROS) Detection
Intracellular ROS levels were detected by flow cytometry using
carboxy-H2DCFDA (C400), as probe, according to the manufac-
turer’s instructions. Within cells, carboxy-H2DCFDA is hydro-
lyzed by esterase to form a non-fluorescent polar derivative, which
is oxidized by intracellular ROS to form the fluorescent compound
29,79-dichlorofluorescein (DCF), whose emission maximum is at
520 nm. Control and H-RasV12 cells were trypsinized, washed
twice with cold PBS and suspended at a final concentration of
0,56106 cell/ml in prewarmed PBS containing the probe at
a working concentration of 10 mM, then incubated for 30 minutes.
As positive control, cells treated with 250 mM of H2O2 for 20
minutes on ice were used. After incubation, cells were washed
twice in PBS and labelled with 20 mg/ml PI, in order to remove
false negative results due to cells with compromised plasma
membrane. Fluorescence of labelled cells was measured on
a Beckman Coulter EPICS XL flow cytometer using an excitation
wavelength of 488 nm. For each sample, the fluorescence intensity
of 10,000 negative PI cells was recorded.
Total Antioxidant Capacity
Total antioxidant capacity for peroxyl radicals was evaluated
using TOSC assay, which measures the ability of cellular
antioxidants to absorb oxyradicals artificially generated by 2-29-
azo-bis-(2 methylpropionamidine)-dihydrochloride (ABAP), a re-
action inhibiting the oxidation of a-keto-c-methiolbutyric acid
(KMBA) to ethylene. Reactions were conducted using 50 ml of cell
extracts and 2 mM KMBA, 20 mM ABAP in 100 mM potassium
phosphate buffer, pH 7.4, as previously reported [36]. TOSC
values were quantified using the equation: TOSC=1002(SA/
CA6100), where SA is the integrated area calculated under the
least squares kinetic curve produced during the sample reaction
and CA is the integrated area calculated under the least squares
kinetic curve produced during the reaction for the control. For all
measurements, TOSC values were referred to the protein
concentration of each sample.
Biochemical Analysis
Total glutathione (GSH+GSSG), oxidize glutathione (GSSG)
and total thiol groups were measured spectrophotometrically by
the glutathione reductase (GR) recycling assay at 412 nm in the
presence of 5,59-dithiobis(2-nitrobenzoic) acid (DTNB) [37].
Briefly, the absorbance at 412 nm generated by DTNB was
measured and then GSH and GSSG concentration were
calculated using a calibration line obtained with known concen-
trations of GSH and GSSG. For sample preparation, transfected
cells were trypsinized and washed twice in cold PBS. For total
GSH/GSSG determination, after cell centrifugation, the pellet
was resuspended with 1% sulfosalicilic acid, vortexed and then
incubated 30 minutes at 4uC. Samples were then centrifuged for 2
minutes at 2,300 g. Supernatant was recovered and divided in two
aliquots: one was conserved at 4uC for GSH quantification, the
other one was treated with 2-vinilpiridin (Cf = 5%) and triethano-
lamine 20% (Cf = 1%) to mask the GSH present in the extract and
prevent its measurement. Pellet was resuspended with 1 M NaOH
for recovery and quantification of proteins. Total thiol groups were
analyzed on total cell extracts.
Glutathione reductase (GR) activity was measured using the
method described by Carlberg and Mannervik [38].The assay
evaluates the decrease in absorbance at 340 nm due to NADPH
oxidation during the reduction of GSSG
(e=26.22 mM21 cm21). The assay was carried out in 100 mM
sodium phosphate pH 7.0 buffer, 0.1 mM NADPH and 1 mM
GSSG. The activity of GR was calculated using an extinction
coefficient for NADPH of 6.22 mM21Ncm21 and the results were
expressed as mmol of NADP+ per minute per mg of proteins.
Glutahione-S-transferase (GST) activity was measured following
the method described by Habig and colleagues [39], using 1-
chloro-2,4-dinitrobenzene (CDNB) as substrate at 340 nm. The
assay was carried out in 100 mM sodium phosphate pH 6.5
buffer, 1 mM CDNB and 1 mM GSH. GST activity, defined as
the amount of enzyme producing 1 mmol of CDNB-GSH
conjugate/min under the conditions of the assay, was calculated
using an extinction coefficient for CDNB of 9.6 mM21Ncm21.
Results were expressed as mmol of CDNB-GSH conjugates per
minute per mg of proteins.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) activity
was measured spectrophotometrically at 25uC by monitoring the
decrease in absorbance of NADH for 1 min at 340 nm [40].
The reaction mixture contained 0.1 M potassium phosphate
buffer, pH 7.6, 6 mM glycerate 3-phosphate, 1.1 mM ATP,
transfected cells using PI (40 mg/ml) as probe. Percentage of fluorescent cells for sub G0, G0/G1, S and G2/M phases were reported in the bottom
panel. Mean 6 s.e.m. of three analyses is reported. E) Cell proliferation measured by BrdU incorporation in newly synthesized DNA using
immunostaining and flow citometry analysis. Control and H-RasV12 transfected cells were treated with 40 mM BrdU for 30 minutes and analyzed after
3, 6, 18 and 24 h. Cells without BrdU were used as negative control according to the manufacture’s instruction. Values of the BrdU positive cells are
given as mean 6 s.e.m. of three independent experiments subtracting the relative negative control. **P,0.01.
doi:10.1371/journal.pone.0052151.g001
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0.9 mM EDTA, 1.7 mM MgSO4, 0.02 mM NADH, 14.8
units/ml phosphoglycerate kinase (E.C.2.7.2.3). Results were
expressed as mmol of GAPDH per minute per mg of proteins.
Morphology Analysis
Pellets were fixed in 2% (v/v) glutaraldehyde in 0.1 M sodium
cacodylate buffer (pH 7.4) for 1 h at 4uC, washed in the same
buffer added with 7% sucrose and post-fixed in 1% OsO4 in
0.1 M sodium cacodylate buffer for 1 h at 4uC. Pellets were then
washed three times in 0.1 M sodium cacodylate buffer, dehydrated
with a graded alcohol series (70%, 95%, and 100%) and propylene
oxide, then embedded in araldite resin and polymerized for 48 h
at 60uC. Semi-thin sections stained with toluidine blue were
examined with a light microscope (Eclipse E 600, Nikon, Italy).
Images were recorded with a Nikon Coolpix digital camera
(Nikon, Italia). Ultrathin sections were cut with an LKB NOVA
ultratome (Bromma, Sweden), placed onto copper grids and
stained with 1% (w/v) uranyl acetate in alcohol solution and lead
citrate. Ultrastructural analysis and photomicroscopy were
performed with a CM 12 transmission electron microscope
(Philips; Endhoven, the Netherlands) at 100 kV. Images were
recorded by an SIS Mega View III TEM CCD Camera
(Olympus; Mu¨nster, Germany).
Immunoblotting
Cell proteins (30 mg) were electrophoresed on 10% acrylam-
ide/bis-acrylamide gel at 150 V for 1 h. Proteins were trans-
ferred to PVDF membrane at 100 V for 1 h. Membrane was
Figure 2. Effect of H-RasV12 on cell vitality. A) Semi-thin sections of control and H-RasV12 cells obtained by light micrographs, 406original
magnification. Black arrows indicate the presence of vacuolization. B) Ultrastructural analysis of control (left photo) and H-RasV12 cells (right photo)
obtained by transmission electron microscope (Philips; Endhoven, the Netherlands) at 100 kV. White arrows indicate macro-vacuolization and
undigested material. C) Annexin-V FITC flow cytometry analysis for apoptosis. Control cells are indicated in grey, H-RasV12 transfected cells are
indicated in black. In the table results are the mean 6 s.e.m of percentage values for normal, apoptotic and necrotic cells in three independent
experiments. D) Senescence-associated b-galactosidase staining of control and H-RasV12 cells. Percentages of SA-b-gal positive cells were counted at
least on five different fields in three independent experiments. **P,0.01.
doi:10.1371/journal.pone.0052151.g002
Figure 3. Analysis of cell redox state. A) Measurement of ROS production. Carboxy-H2DCFDA (C400) probe was used to analyze ROS
concentration in control and H-RasV12 transfected cells by flow cytometry. In the left panel % of ROS production was reported as fluorescence
arbitrary units, obtained by subtraction of PI to carboxy-H2DCFDA. In the right panel cytometric graphs were reported for control cells (black), H-
RasV12 cells (dark grey), in comparison with positive control cells treated with 250 mM H2O2 (light grey). B) Total antioxidant capacity for control and
H-RasV12 transfected cells. Results reported are the mean values 6 s.d. of three different experiments. C) Quantification of thiol groups which are
present in total protein fraction. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0052151.g003
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blocked by 5% non-fat dry milk in Tris-buffered saline with
0.1% Tween 20 (TBST) at room temperature for 1 h. Mouse
monoclonal anti-GSH antibody and rabbit polyclonal anti-HRas
antibody were used to analyze the S-glutathionylation levels in
control and H-RasV12 transfected samples. As negative control,
samples were treated with 25 mM DTT. As internal control,
membranes were probed with mouse monoclonal anti b-actin.
In Dot Blot analysis 3 mg of protein extract were serially diluted
1:2 till 1:256 and spotted into a nitrocellulose membrane. Goat
anti-mouse and goat anti-rabbit HRP-linked secondary anti-
Figure 4. Measurement of glutathione concentration, glutathione dependent enzymes and GAPDH. Total cellular GSH (A) and GSSG (B)
were determined for control and H-RasV12 cells by DTNB-GSSG reductase recycling assay. The amount of GSH or GSSG was normalized for proteins
content. Values are the mean 6 s.d. of six different experiments. Enzyme activity of C) glutathione reductase, D) glutathione-S-transferase and E)
glyceraldehyde 3-phosphate dehydrogenase was determined spectrophotometrically at 340 nm. Results reported are mean values 6 s.d. of six
different experiments. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0052151.g004
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bodies were used according to manufacturer’s instructions.
Immunoblots were detected by chemiluminescence using ECL
(GE Healthcare Uppsala, Sweden).
2-D Electrophoresis
Control and H-RasV12 transfected cells were harvested and
resuspended with 8 M urea and 4% CHAPS to allow the recovery
of total protein extracts, then quantified by Bradford assay. First
dimension (isoelectrofocusing, IEF) was performed using a 7 cm
ImmobilineTMDryStrip pH 3–10 non linear. Strips were actively
rehydrated in the presence of 100 mg of each sample at 30 V for
12 h in an IPG-phor system (Amersham Pharmacia, Amersham,
UK). After rehydration, IEF runs were carried out at 20uC based
on current limit of 50 mA/IPG-strip as follows: 300 V for 1 h,
3000V for 3 h (gradient) and 3000 V until 15000 V/h was
reached in total. After IEF, IPG-strips were equilibrated in a buffer
containing 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, 50 mM
Tris-HCl pH 8.8 for 30 minutes. SDS-PAGE (second dimension)
was performed using 10% acrylamide/bis-acrylamide gel and
carried out at 90 V for 130 minutes. First and second dimensions
were carried out in non reducing conditions to avoid bonds
disruption between protein free cysteinyl groups and GSH. Gels
were then blotted on PVDF membrane by semi-dry method at
100 mA (0.8 mA/cm2) for 75 minutes. A total protein loading
control was performed loading 20 mg of the same extracts used for
2-D electrophoresis in 10% acrylamide/bis-acrylamide gel. At the
end gel was staining with Coomassie Blue and total protein
intensity was evaluated.
Figure 5. Analysis of protein S-glutathionylation. A) Immunoblotting with anti-GSH antibody of control (lanes 1, 3) and H-RasV12 expressing
cells (lanes 2, 4). Proteins (30 mg) were electrophoresed on 10% acrylamide/bis-acrylamide gel. Cell extracts were obtained either in non-reducing
(lanes 1, 2) or in reducing (lanes 3, 4) conditions, by means of 25 mM DTT addition prior to loading. An anti-b actin antibody was used as internal
control. B) Densitometric analysis of total bands intensity of immunoblotting was reported. No statistical difference of total glutathionylated proteins
were observed in H-RasV12 expressing cells in comparison with the control cells C) Dot blot analysis was reported. 3mg of protein extract were serially
diluted 1:2 till 1:256, spotted into a nitrocellulose membrane and immunoblotted with anti GSH antibody. D) Densitometric analysis of dot blot
showed no statistical difference in H-RasV12 expressing cells in comparison with the control cells.
doi:10.1371/journal.pone.0052151.g005
H-Ras Induced Changes of S-glutathionylation
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e52151
Mass Spectrometry Analysis
Protein identification was carried out by peptide mass finger-
printing (PMF) on Ettan MALDI-TOF Pro mass spectometer (GE
Healthcare) as previously described [41]. After visualization by
colloidal Comassie staining protocol, spots were mechanically
excised, destained in 2.5 mM ammonium bicarbonate and 50%
(v/v) acetonitrile and finally dehydrated in acetonitrile. They were
then rehydratated in trypsin solution and in-gel protein digestion
was performed by overnight incubation at 37uC. Each protein
digest (0.75 mL) was spotted onto the MALDI target and allowed
to air dry. Then 0.75 mL of matrix solution (saturated solution of
a-cyano-4-hydroxycinnamic acid in 50% (v/v) acetonitrile and
0.5% (v/v) TFA) was applied to the sample which was dried again.
Mass spectra were acquired automatically using the Ettan MALDI
Evaluation software (GE Healthcare). Recorded spectra were
calibrated using, as internal standard, the 842.509 and
2211.105 m/z peptides arising from trypsin autoproteolysis. The
resulting mass lists were filtered for contaminant removal: mass
Figure 6. Evaluation of protein S-glutathionylation patterns. Evaluation of protein S-glutathionylation patterns was performed by 2D-
immunoblotting with anti-GSH antibody: A) control cells. B) H-RasV12 expressing cells. 100 mg of total cell extracts were separated on non- linear
pH 3–10 strips (7 cm) for first dimension and then loaded on 10% acrylamide/bis-acrylamide gels for second dimension. Gels were blotted on PVDF
membrane. Black rounds highlight protein spots which present a different level of S-glutathionylation. C) Total loading control. A total of 20 mg of
cellular extract proteins used for 2D-immunoblotting was loaded on 10% acrylamide/bis-acrylamide gel and stained with Coomassie Blu.
doi:10.1371/journal.pone.0052151.g006
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matrix-related ions, trypsin auto-lysis and keratin peaks. Protein
identification by Peptide Mass Fingerprints search was performed
using MASCOT version 2.2 as the search engine (Matrix Science,
London, UK, http://www.matrixscience.com) with the Swiss-
Prot/UniprotKB database. Taxonomy was limited to Homo sapiens,
a mass tolerance of 100 ppm was allowed and the number of
accepted missed cleavage sites was set to one. Alkylation of
cysteine by carbamidomethylation was considered as a fixed
modification, while oxidation of methionine was considered as
a possible modification. The criteria used to accept identifications
included the extent of sequence coverage (at least 10%), the
number of matched peptides (at least 5) and a probabilistic score at
p,0.05.
Treatment of the H-RasV12 Expressing Cells with
Antioxidants
At the end of selection H-RasV12 expressing cells were treated
with an antioxidants mix (0.5 mM GSH ethyl ester, 50 mM a-
tocopherol and 1.5 mM vitamin C). The treatment was repeated
every 24 hours. Cell growth was determined by counting cell
numbers in a haemocytometer. The viability of the cells was
estimated by examining their ability to exclude Trypan blue (0.1%
in 0.9% NaCl).
Statistical Analysis
Data were presented as mean 6 s.d or mean 6 s.e.m. Statistical
comparison of differences among groups of data was carried out
using a Student’s t-test. P-values #0.05 were considered statisti-
cally significant and P-values #0.01 were considered highly
significant.
Results
Oncogenic H-RasV12 Expression Results in no Increase in
Cell Population and Arrest of Cell Cycle
Human fibroblasts (HuDe) were transfected with a pcDNA6
plasmid coding for H-RasV12, a mutant of the effector domain of
H-Ras which is constitutively activated, as the mutation makes the
GTPase unable to hydrolyze GTP. HuDe were also transfected
with the pcDNA6 vector alone as control, and very high levels of
Ras expression were detected by immunoblotting (Fig. 1A).
Expression of the constitutively activated oncogene H-RasV12
has been previously reported to lead to an arrest of cell
proliferation in 1–3 days from clone selection [10]. Microscope
analysis of cells transfected with H-RasV12 showed a senescent
phenotype within one day from the end of the selection, with
a flattened cellular morphology, followed by detachment from the
adhesion surface (Fig. 1C). Besides, H-RasV12 transfected cells
showed a cell growth arrest that was already evident one day after
the end of the selection, compared to cells transfected with the
empty vector alone as control (Fig. 1B). Interestingly, analysis by
flow cytometry showed that significant fractions of H-RasV12
expressing cells are still in G0/G1 and S-phase of the cell cycle
(Fig. 1D), despite their arrested state and altered morphology.
Indeed, cell cycle analysis showed that transfected cells had
a 14.3% reduction of G0/G1 phase cells and a 6.4% increase of
G2/M phase cells, in comparison with control cells. Moreover
a 5.2% increase of cells in sub-G0 phase was present in H-RasV12
expressing cells compared to the control, suggesting a possible
apoptosis induction (Fig. 1D). BrdU analysis showed a meaningful
decrease in BrdU incorporation in H-RasV12 cells after 24 h from
treatment (Fig. 1E), indicating an arrest of cell cycle. Indeed, while
control cells tranfected with empty vector showed about 70% of
positivity to BrdU, which remains constant over 24 h, H-RasV12
Table 1. Mass spectrometry analysis of glutathionylated proteins.
Spot Numbera
Accession
Numberb Mascot Search Results
c
MW (Da) Calculated pI Protein
Matched Peptide/
Searched Peptide
Sequence
Coverage Score
7 P06576 20/34 41% 179 56525 5.26 ATP synthase subunit beta,
mitochondrial
8 P08670 12/15 26% 142 53776 5.06 Vimentin
11a P06733 16/23 38% 144 47481 7.01 Alpha enolase
11b P06733 9/23 18% 73 47481 7.01 Alpha enolase
aSpot numbers match those reported in the representative 2-DE images shown in Fig. 6.
bAccession number in Swiss-Prot/UniprotKB.
cMASCOT search results: number of matched peptides correspond to peptide masses matching the top hit from Ms-Fit PMF, searched peptide are also reported;
sequence coverage indicates [number of identified residues/total number of amino acid residues in the protein sequence]6100%; score corresponds to MASCOT score
(MatrixScience, London, UK; http.//www.matrixscience.com).
doi:10.1371/journal.pone.0052151.t001
Figure 7. Effect of antioxidant mix on H-RasV12 cell popula-
tion. Growth curve of HuDe fibroblasts transfected with H-RasV12
treated with 0.5 mM GSH ethyl ester, 50 mM a-tocopherol and 1.5 mM
vitamin C. The cell number increase after the end of selection with
Blasticidin-S is reported and results were compared with growth curve
obtained for control and H-RasV12 transfected cells. Mean values were
calculated on 5 replicates and mean 6 s.d. was indicated for each
sample. *P,0.05.
doi:10.1371/journal.pone.0052151.g007
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cells showed a drop off in BrdU positivity from about 60% after
3 h to 6% after 24 h.
Oncogenic H-RasV12 Promotes Premature Senescence
followed by Cell Death through Autophagy and
Apoptosis
Oncogenic H-RasV12 has been previously described to induce
cell death by different mechanisms, such as premature senescence,
apoptosis and autophagy [5]. The morphology of H-RasV12
expressing cells is dramatically different when compared with that
of cells transfected with the vector alone as control. In particular
morphological semi-thin sections (Fig. 2A) showed a wide cytosolic
vacuolization in H-RasV12 expressing fibroblasts, which is usually
considered as evidence that cell death is induced as a result of
prolonged autophagy [4]. Indeed electron microscopy showed
numerous vacuoles with undigested material and mitochondrial
autophagy in H-RasV12 expressing cells that indicated macro-
autophagy processes (Fig. 2B). Besides some nuclei showed
apoptotic chromatin and the annexin V-FITC analysis confirmed
a higher percentage of phosphatidylserine out of the cell
membrane (+15%) in H-RasV12 expressing cells, thus suggesting
the induction of apoptosis (Fig. 2C). To assess the induction of
premature senescence, we measured the activity of senescence-
associated b-galactosidase activity (SA-b-gal), a lysosomal enzyme
that is a well known marker of senescence [42]. Results confirmed
that many H-RasV12 expressing cells showed premature aging
within one day from the transfection (Fig. 2D). All this evidence
taken together confirmed that expression of constitutively active
H-Ras oncogene promotes premature senescence followed by cell
death.
Constitutively Activated Oncogene H-Ras Induces
Cellular Redox Imbalance
To identify other mechanisms possibly acting as oncogenic
barriers during OIS, we evaluated cellular redox balance assessing
both reactive ROS production and total antioxidant capacity in
cells expressing with H-RasV12, compared with control cells.
ROS concentration was significantly higher in H-RasV12 cells
with respect to the control but was lower compared to the control
cells treated with H2O2 (Fig. 3A). Also we observed a strong
significant depletion of total antioxidant capacity in H-RasV12
transfected cells, as demonstrated by the measurement of cell
antioxidant defence against peroxyl radical (Fig. 3B) and
significant depletion of total thiol groups (Fig. 3C). Since GSH is
the main and most abundant anti-oxidant molecule in the cell, we
supposed that depletion of total antioxidant capacity could be due
primarily to the reduction of total GSH concentration. In fact
concentration of total GSH was significantly lower in H-RasV12
expressing cells compared to control cells, and GSSG also showed
to be depleted in H-RasV12 transfected cells (Fig. 4 A,B). As cells
transfected with H-RasV12 showed depletion of both total GSH
and oxidized GSSG, the GSH:GSSG ratio remained unchanged
(control cells 26,961.3 and H-RasV12 cells 28,861.5). We also
determined the activity of two enzymes involved in GSH
metabolism and observed that the activity of the GR and GST
showed a significant decrease in H-RasV12 cells compared with
control cells (Fig. 4 C,D). Total GSH is known to be used by cells
for many purposes but the unchanged GSH:GSSG ratio may
indicate that the cells can utilizes both GSH and GSSG and both
forms of glutathione could be used to bind free sulphydryl groups
of proteins to cysteine. Moreover, previous study showed a re-
lationship between senescence and GAPDH activity and we chose
this enzyme to evaluate its activity in relationship with oncogene
H-Ras expression. We observed a significant depletion of GAPDH
activity in H-RasV12 transfected cells (Fig. 4E) compared to the
control cells.
Constitutively Activated Oncogene H-Ras Modifies
Protein S-glutathionylation
Due to the importance of protein S-glutathionylation in
protecting proteins from oxidative stress, in signal transduction
and in the modulation of protein function, we investigated protein
S-glutathionylation by immunoblotting and dot blot using an anti-
GSH antibody. No statistical difference of total glutathionylated
proteins were observed in H-RasV12 expressing cells in compar-
ison with the control (Fig. 5 A, B, C, D) but single bands always
showed different trend levels of glutathionylated proteins in H-
RasV12 expressing cells with respect to the control cells. Two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE),
followed by western blotting analysis using the anti-GSH antibody
(Fig. 6 A, B), was performed to analyse the pattern of
glutathionylated proteins. Interestingly, as reported in Fig. 6, H-
Ras V12 expressing cells displayed a complex pattern of protein S-
glutathionylation, significantly different from their control coun-
terparts. In particular, spots labelled from 1 to 6 were present in
control cells but disappeared in H-RasV12 expressing cells,
whereas spots from 7 to 12 were not detectable in control cells
but were significantly S-glutathionylated in H-RasV12 expressing
cells. In addition, a significant decrease of S-glutahionylation was
detected for spot 13 in H-RasV12 cells, whereas an increase was
detected for spots 14 and 16. Furthermore, a very intense spot
(black arrow) also clearly displayed a different S-glutathionylation
pattern upon H-RasV12 expression. Overall results provided
strong evidence that H-RasV12 expression modified human
fibroblasts S-glutathionylation pattern in a very specific manner.
In order to identify the glutathionylated spots, a preparative gel
was performed and stained with colloidal Coomassie. The Western
blot images were matched to the corresponding colloidal
Coomassie stained 2-DE gels using ImageMaster 2D-Platinum
software and spots corresponding to glutathionylated proteins
were cut and subjected to mass spectrometry analysis. The
increment of protein load in preparative gels caused an expected
loss of separative power and some spots clearly present in western
blot, were not distinctly detected and resolved in Coomassie
stained gels. Among the glutathyonilated proteins we were able to
identify spots 7, 8 and 11a and 11b by mass spectrometry. Mass
data of the spots were reported in Table 1.
Treatment with Antioxidants Mix Induced a Transient
Recovery of H-RasV12 Expressing Cells
The treatment of H-RasV12 expressing cells with antioxidants
mix resulted in a transient recovery of cell growth, as cell
population increases only at a day 1 from the end of selection
(Fig. 7). To not interfere with the transfection the treatment was
carried out at the end of the selection. In these conditions, cells
certainly suffered DNA hyper-proliferation and senescence path-
ways activation. Nevertheless it was possible to observe a modest
recovery, of treated cells growth. This positive trend may indicate
an insufficient role of antioxidant defence in the context of induced
senescence.
Discussion
Uncontrolled cell proliferation and oncogenic transformation of
primary cells require oncogene deregulation and activation of the
cooperating mechanism. Indeed only constitutively activated
oncogene H-RasV12 is known to induce premature senescence
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which is considered like a first barrier to oncogenic cell progression
[7,10].In this work we report that, despite cell growth arrest and
altered morphology, H-RasV12 expressing cells are actually
distributed in all phases of the cell cycle, thus suggesting the
activation of DNA damage checkpoints at multiple phases of cell
cycle. In addition, we also observed an increase of cell death by
apoptosis and autophagy. These results suggest complex dynamics
of premature senescence and cell death induced by oncogene
activation, whose elucidation is very important for understanding
how cells escaping from proliferation barriers can acquire
a progressively aberrant oncogenic potential. Previous studies
showed that oncogenic H-Ras induces proliferative arrest or
senescence by activating S-phase-specific DNA-damage check-
point response (DDR) followed by apoptotic cell death [10] or that
the expression of oncogenic H-Ras leads to caspase-independent
cell death with autophagy features [4]. In this study we propose
a role of the cellular redox balance in premature senescence and
death induced from activated oncogene H-RasV12. On the other
hand activated H-Ras has been shown to promote ROS pro-
duction in a variety of human cancer cell types including
transformed embryonic lung cells, fibroblasts, neuroblastoma cells
as well as in hematopoietic progenitor cells where the promotion of
superoxide and H2O2 production through activation of NADPH
oxidase was shown [43–46]. Furthermore it has also been
demonstrated that activation of H-Ras and ERK, in human renal
cancer cells, promoted nuclear translocation of the transcription
factor Nrf2 for its binding to the multiple sequence codified
proteins link to antioxidant cellular defences [47]. Many studies
have been conducted in human cancer cells but this study is the
first one that has considered cellular redox balance in OIS
condition activated by H-Ras.
We observed that in OIS human fibroblasts expressing H-
RasV12 cellular redox imbalance was mainly caused by depletion
of total antioxidant capacity rather than by a high increase in
oxidant level. In fact, we did not observe high ROS production in
cells over-expressing active H-Ras, but detected a remarkable
reduction of antioxidant capacity. This could arise as a response to
the weak but chronic oxidative stress due to DNA hyper-
proliferation and/or to GSH consumption. In effect, according
to the lower antioxidant capacity, we also observed a remarkable
depletion of GSH, which is the cell most abundant in antioxidants
and it is generally considered to influence the cell redox balance by
helping to maintain a reduced intracellular environment. GSH
fulfils a range of cellular functions from detoxification to protection
from oxidative damage. It is also considered crucial in several
cellular processes including cell differentiation, programmed cell
death and cell cycle regulation [29]. Interestingly, some studies
reported that cells with high proliferation rate have high GSH
levels and tumor cells typically show high levels of GSH and
consequently high antioxidant defenses [31–33]. Taken together,
these data suggest that cells, which are able to maintain high levels
of GSH, can escape the oncogenic barrier established following
oncogene activation, whereas OIS is associated with the mainte-
nance of low levels of antioxidant capacity.
On the contrary it was previously reported that treatment of
cells with N-acetyl cysteine only marginally inhibits DNA-damage
responses induced by oncogenic activation, which suggests OIS
may occur independently from ROS levels [17,48]. We showed
that the treatment of active H-Ras expressing cells with
antioxidants mix did not result in a significantly different cell
growth compared to control cells (only a transient improvement),
indicating that the treatment is not fully effective in bypassing
senescence. To summarize, it was reported high levels of GSH in
tumour cells [31,33], and we observed low levels of GSH in OIS
cells but the external supply of antioxidants did not radically
change the induction of senescence. We can therefore assume that
the level of GSH in the cell is important in the context of
proliferation and that this level is adjusted internally by the cell
and is independent of the availability of precursor molecules. In
our study we observed depletion of GSH and also GSSG so we
assumed that GSSG, produced during DNA iper-proliferation
stress, could to be used for the glutathionylation of proteins. In this
way a molecule of GSH could bind to cysteine residues of the
protein to protect it from oxidation while the other molecule
reconstituted the GSH cell levels. This supposition is also
strengthened by the lower activity of glutathione reductase enzyme
observed in H-Ras-expressing cells. S-glutathionylation can serve
as a protective mechanism against cysteine oxidation and is
recognized to be an important component of cellular redox
signalling [49–51].
In our study we report a change in S-glutathionylation pattern
in active H-RasV12 expressing cells. These findings suggest that
cells may utilize GSH in post-translation protein modification
thereby creating regulatory mechanisms related to cell survival. As
a matter of fact, S-glutathionylation of several proteins has been
reported, including many proteins involved in cell cycle control
and cell death such as GAPDH, NF-kB p65, caspase-3, p53, ERK,
JNK, ATP synthase, actin and others [23,52].
In this work we identify vimentin, ATP synthase b-subunit and
a-enolase, (already known to be S-glutathionylated) [53–55] which
are more glutathionylated in H-RasV12 cells compared to the
control. This modification may play a substantial role in OIS and/
or oncogenic phenotypes. For example it was seen that both ATP
synthase b-subunit and a-enolase are inhibited by cysteine
modifications [53,55], while there is no information about the
effect on vimentin glutathionylation. Moreover it has been
demonstrated that these proteins are involved both in senescence
and in cancer progression phenomena [56–59]. The exact
function of this reversible oxidative post-translational modification
is unknown. Further studies investigating the specific in vivo effects
of S-glutathionylation in oxidative stress are important to de-
termine the role of S-glutathionylation during OIS and tumor
progression.
Several studies have shown that many proteins can be
glutathionylated or deglutathionylated during oxidative stress
and in this study we demonstrate that the glutathionylation of
proteins is also present during OIS. In agreement with our
findings, Andrei et al. demonstrated that in some cancer cell lines
proliferation inhibitors rapidly induce a substantial increase of
protein S-glutathionylation levels [60], thus indicating that this
event may be of relevance in the evaluation of therapeutic agents.
In conclusion our results provide evidence that GSH levels
decreased and protein S-glutathionylation is altered in human
fibroblasts during OIS, so GSH levels and S-glutathionylation may
be considered as additional barriers to oncogenic transformation.
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